PHI with Thromboangiitis obliterans
How does this condition affect your private health insurance?
Thromboangiitis obliterans (Buerger's disease) is a rare, non-atherosclerotic inflammatory occlusive disease affecting small and medium-sized arteries and veins, predominantly in the distal extremities. It is profoundly linked to tobacco use. The condition causes segmental thrombotic occlusion, leading to severe ischemia, pain at rest, ulceration, and gangrene of fingers and toes. Symptoms often include Raynaud's phenomenon, claudication in the feet or hands, and cold sensitivity. Without complete and sustained abstinence from tobacco, the disease progresses relentlessly, frequently necessitating multiple amputations. Treatment focuses primarily on immediate cessation of all tobacco products, meticulous wound care, pain management, and sometimes vasodilators or surgical sympathectomy to improve blood flow. It profoundly impacts quality of life.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 50%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Gradual onset over weeks to months, with initial symptoms persisting and often worsening.
Duration of Illness (Lifetime)
Chronic and progressive, often lifelong unless complete tobacco cessation is achieved.
Cost of Treatment (Initial)
Moderate to high, potentially thousands to tens of thousands of dollars for initial diagnosis and management of acute symptoms, including wound care and pain control.
Cost of Treatment (Lifetime)
Very high, potentially hundreds of thousands of dollars over a lifetime, especially with recurrent episodes, amputations, and long-term rehabilitation.
Mortality Rate
Low directly, but increased risk due to severe complications like overwhelming infections from gangrene or systemic issues in advanced stages.
Risk of Secondary Damages
High (e.g., tissue necrosis, chronic severe pain, recurrent infections, multiple amputations of digits or limbs, psychological distress, significant functional impairment).
Probability of Full Recovery
Low without complete and sustained cessation of tobacco use; high probability of progression and recurrence if smoking continues. Reversal is possible in early stages with strict abstinence.
Underlying Disease Risk
Low for other primary underlying diseases causing TAO; however, patients often have other tobacco-related conditions (e.g., chronic obstructive pulmonary disease, coronary artery disease) due to shared risk factor.